Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring

por Latimer, N. R., Abrams, K. R., Siebert, U.
Publicado 2019

Assessing causal treatment effect estimation when using large observational datasets

por John, E. R., Abrams, K. R., Brightling, C. E., Sheehan, N. A.
Publicado 2019

Jointly modelling longitudinally measured urinary human chorionic gonadotrophin and early pregnancy outcomes

por Ashra, N. B., Marriott, L., Johnson, S., Abrams, K. R., Crowther, M. J.
Publicado 2020

PReS-FINAL-2330: Canakinumab treatment in patients with HIDS

por Antón, J, Calvo, I, Robles, A, Yagüe, J, Aróstegui, J, Viana, R, Bhansali, S, Abrams, K
Publicado 2013

PReS-FINAL-2169: Exposure-response modeling of canakinumab in the avoidance of flares in children with systemic juvenile idiopathic arthritis

por Xiong, Y, Wang, W, Ebling, W, Sun, H, Luttringer, O, Abrams, K, Ruperto, N, Brunner, H
Publicado 2013

OR10-006 - Canakinumab in patients with TRAPS

por Lachmann, HJ, Obici, L, Meini, A, Tormey, V, Abrams, K, Davis, N, Andrews, C, Bhansali, SG, Gattorno, M
Publicado 2013

Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future

por Riley, R D, Abrams, K R, Sutton, A J, Lambert, P C, Jones, D R, Heney, D, Burchill, S A
Publicado 2003

Efficacy, safety, and post-vaccination antibody titer data in children with CAPS treated with Canakinumab

por Brogan, P, Hofer, M, Kuemmerle-Deschner, J, Lauwerys, B, Speziale, A, Abrams, K, Leon, K, Wei, X, Laxer, R
Publicado 2015

The status of HPD programs at Brookhaven National Laboratory

por Abrams, K, Cockrill, J, Connolly, P, Crennell, D, Hough, P V C, Plotter, L, Stonehill, D, Strand, R, Thompson, W
Publicado 1965

Pharmacokinetics of Canakinumab in children younger than 2 years old with CAPS

por Kalabus, J, Brogan, P, Hofer, M, Kuemmerle-Deschner, J, Lauwerys, B, Speziale, A, Laxer, R, Sun, H, Abrams, K, Leon, K, Junge, G
Publicado 2015

Gene expression profiling in understanding the molecular pathogenesis of and response to canakinumab therapy in traps

por Gattorno, M, Torene, R, Lachmann, H, Obici, L, Meini, A, Tormey, V, Caorsi, R, Baeriswyl, L, Affentranger, U, Starck-Schwertz, S, Letzkus, M, Hartmann, N, Abrams, K, Nirmala, N
Publicado 2014

Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis

por Quartier, P, Grom, A, Ruperto, N, Brunner, HI, Schikler, K, Erguven, M, Goffin, L, Hofer, M, Kallinich, T, Marzan, K, Gaillez, C, Lheritier, K, Abrams, K, Martini, A, Lovell, DJ
Publicado 2014

Canakinumab treatment shows maintained efficacy in systemic juvenile idiopathic arthritis patients

por Wulffraat, NM, Ruperto, N, Brunner, HI, Oliveira, S, Uziel, Y, Nistala, K, Cimaz, R, Ferrandiz, MA, Flato, B, Gamir, M, Kone-Paut, I, Gaillez, C, Lheritier, K, Abrams, K, Martini, A, Lovell, D
Publicado 2014

PReS-FINAL-2158: Effect of canakinumab on functional ability and health-related quality of life in systemic juvenile idiopathic arthritis (SJIA) patients

por Quartier, P, Ruperto, N, Wulffraat, N, Brunner, H, Brik, R, Mccann, L, Foster, H, Frosch, M, Gerloni, V, Harel, L, Len, C, Houghton, K, Joos, R, Abrams, K, Lheritier, K, Kessabi, S, Martini, A, Lovell, D
Publicado 2013

PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis

por Quartier, P, Brunner, H, Constantin, T, Padeh, S, Calvo, I, Erguven, M, Goffin, L, Hofer, M, Kallinich, T, Oliveira, S, Uziel, Y, Viola, S, Nistala, K, Wouters, C, Lheritier, K, Hruska, J, Abrams, K, Martini, A, Ruperto, N, Lovell, D
Publicado 2013

Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever

por Horneff, G, Ruperto, N, Brunner, H, Quartier, P, Constantin, T, Alexeeva, E, Kone-Paut, I, Marzan, K, Wulffraat, N, Schneider, R, Padeh, S, Chasnyk, V, Wouters, C, Deschner, J Kummerle, Kallinich, T, Lauwerys, B, Haddad, E, Nasonov, E, Trachana, M, Vougiouka, O, Abrams, K, Leon, K, Lheritier, K, Martini, A, Lovell, D
Publicado 2015

PReS-FINAL-2156: Analysis of gene expression and inflammation biomarkers in systemic juvenile idiopathic arthritis (SJIA) patients on canakinumab therapy

por Nirmala, N, Wulffraat, N, Brunner, H, Quartier, P, Brik, R, Mccann, L, Ozdogan, H, Rutkowska-Sak, L, Schneider, R, Gerloni, V, Harel, L, Terreri, M, Houghton, K, Joos, R, Kingsbury, D, Lopez-Benitez, J, Radominski, S, Brachat, A, Bek, S, Schumacher, M, Valentin, M, Gram, H, Abrams, K, Martini, A, Ruperto, N, Lovell, D
Publicado 2013